LATEST
GTCR agreed to acquire CCC Intelligent SolutionsEQT agreed to acquire StockbridgeProofpoint agreed to acquire VaronisPyrophyte Acquisition . II / SakuuMotown Acquisition agreed to acquire Penske Automotive GroupVivos Therapeutics / SOD SciencesAtlasClear Holdings agreed to acquire Ark Financial ServicesLaboratory of America Holdings / BioReference HealthMubadala Capital acquired Clear Channel OutdoorIthaca Holdings agreed to acquire BumblePenta Fine Ingredients acquired SynerzineHexagon agreed to acquire Rocscience
Open App
Agreement signedPublished 4 Mar 2026

Dr Ashleys Limited /
Impact BioMedical Inc.

Impact BioMedical amends share exchange deal with Dr Ashleys

Buy side: Dr Ashleys Limited
Buy sideDr Ashleys Limited
Target: Impact BioMedical Inc.
TargetImpact BioMedical Inc.
IMPACT BIOMEDICAL INC. · 4 Mar 2026Source
See the source
Buy side: Dr Ashleys Limited
Buy sideDr Ashleys Limited
Target: Impact BioMedical Inc.
TargetImpact BioMedical Inc.
01 / BuyerDr Ashleys Limited
02 / TargetImpact BioMedical Inc.
Source for the buyer and target: IMPACT BIOMEDICAL INC.

For the buyer and target.

“This Amendment No. 1 to Transition Arrangement Agreement, dated as of February 27, 2026 (this “ Amendment No. 1 ”), by and among Dr. Ashleys Limited, a Cayman Islands exempted company (“ PubCo ”), Impact BioMedical Inc., a Nevada corporation (“ Impact ”), Frank D. Heuszel (“ Impact CEO ”), and DSS, Inc. (“ DSS ”).”

Published 4 Mar 2026

Open the source
01

What happened

Impact BioMedical Inc. and Dr Ashleys Limited entered into Amendment No. 1 to their Merger and Share Exchange Agreement on Feb. 27, 2026. The amendment changes share issuance to DSS, Inc. and the Compensation Shares to Impact's chief executive, and moves the End Date to July 1, 2026. Terms weren't disclosed. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · IMPACT BIOMEDICAL INC.

Impact BioMedical amends share exchange deal with Dr Ashleys

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Also stated

    “Impact BioMedical amends share exchange deal with Dr Ashleys Impact BioMedical Inc. and Dr Ashleys Limited entered into Amendment No. 1 to their Merger and Share Exchange Agreement on Feb. 27, 2026”

    Open the source

  2. Published by IMPACT BIOMEDICAL INC.

    The source this page is built from.

    Open the source

  3. Also stated

    “The amendment changes share issuance to DSS, Inc. and the Compensation Shares to Impact's chief executive, and moves the End Date to July 1, 2026”

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.